BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24893363)

  • 1. Linking biochemical pathways and networks to adverse drug reactions.
    Zheng H; Wang H; Xu H; Wu Y; Zhao Z; Azuaje F
    IEEE Trans Nanobioscience; 2014 Jun; 13(2):131-7. PubMed ID: 24893363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of the associations between adverse drug reactions and pathways.
    Chen X; Wang Y; Wang P; Lian B; Li C; Wang J; Li X; Jiang W
    Biomed Res Int; 2015; 2015():670949. PubMed ID: 26495310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases.
    Zheng Y; Peng H; Zhang X; Zhao Z; Yin J; Li J
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):517. PubMed ID: 30598065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model.
    Hwang Y; Oh M; Jang G; Lee T; Park C; Ahn J; Yoon Y
    Mol Biosyst; 2017 Aug; 13(9):1788-1796. PubMed ID: 28702565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale identification of adverse drug reaction-related proteins through a random walk model.
    Chen X; Shi H; Yang F; Yang L; Lv Y; Wang S; Dai E; Sun D; Jiang W
    Sci Rep; 2016 Nov; 6():36325. PubMed ID: 27805066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARWAR: A network approach for predicting Adverse Drug Reactions.
    Rahmani H; Weiss G; Méndez-Lucio O; Bender A
    Comput Biol Med; 2016 Jan; 68():101-8. PubMed ID: 26638149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy.
    Juhlin K; Ye X; Star K; Norén GN
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1119-29. PubMed ID: 23832706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
    Kumlien E; Lundberg PO
    Seizure; 2010 Mar; 19(2):69-73. PubMed ID: 20036167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of drug safety information using large-scale adverse drug reactions database].
    Morikawa K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
    Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.
    Hur J; Özgür A; He Y
    J Biomed Semantics; 2018 Jun; 9(1):17. PubMed ID: 29880031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the causative proteins of similar side effect pairs to explore the common molecular basis of these side effects.
    Wang Y; Chen X; Liu L; Chen Y; Ma H; Yang R; Liu X
    Mol Biosyst; 2015 Jul; 11(7):2060-7. PubMed ID: 25992869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs.
    Liu M; Wu Y; Chen Y; Sun J; Zhao Z; Chen XW; Matheny ME; Xu H
    J Am Med Inform Assoc; 2012 Jun; 19(e1):e28-35. PubMed ID: 22718037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential causal association mining algorithm for screening adverse drug reactions in postmarketing surveillance.
    Ji Y; Ying H; Dews P; Mansour A; Tran J; Miller RE; Massanari RM
    IEEE Trans Inf Technol Biomed; 2011 May; 15(3):428-37. PubMed ID: 21435986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
    Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
    Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network characteristic analysis of ADR-related proteins and identification of ADR-ADR associations.
    Chen X; Liu X; Jia X; Tan F; Yang R; Chen S; Liu L; Wang Y; Chen Y
    Sci Rep; 2013; 3():1744. PubMed ID: 23625301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Assessment of Adverse Drug Reactions by Statistical Solution of Gene Association Network.
    Xiang YP; Liu K; Cheng XY; Cheng C; Gong F; Pan JB; Ji ZL
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(4):844-50. PubMed ID: 26357325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SignalDetDDI: An SAS macro for detecting adverse drug-drug interactions in spontaneous reporting systems.
    Gosho M; Ohigashi T; Maruo K
    PLoS One; 2018; 13(11):e0207487. PubMed ID: 30452488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.